Published in J Cell Mol Med on July 10, 2009
Stem cell technology for neurodegenerative diseases. Ann Neurol (2011) 1.93
Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev (2010) 1.25
Current insights on the regenerative potential of the periosteum: molecular, cellular, and endogenous engineering approaches. J Orthop Res (2012) 1.21
Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease. Mol Neurobiol (2011) 1.11
Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. J Cell Mol Med (2012) 1.08
Directly auto-transplanted mesenchymal stem cells induce bone formation in a ceramic bone substitute in an ectopic sheep model. J Cell Mol Med (2010) 1.07
Concise review: mesenchymal stem cells for diabetes. Stem Cells Transl Med (2011) 1.06
Therapy with stem cells in inflammatory bowel disease. World J Gastroenterol (2014) 1.03
Engineering skeletal muscle tissue--new perspectives in vitro and in vivo. J Cell Mol Med (2010) 1.02
Akt- and Erk-mediated regulation of proliferation and differentiation during PDGFRβ-induced MSC self-renewal. J Cell Mol Med (2012) 1.00
Bone marrow cell cotransplantation with islets improves their vascularization and function. Transplantation (2010) 0.98
New insights into osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells and their potential clinical applications for bone regeneration in pediatric orthopaedics. Stem Cells Int (2013) 0.98
Decellularized tissue-engineered heart valve leaflets with recellularization potential. Tissue Eng Part A (2012) 0.95
Stem cell labeling using polyethylenimine conjugated (α-NaYbF4:Tm3+)/CaF2 upconversion nanoparticles. Theranostics (2013) 0.93
Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury. Invest Ophthalmol Vis Sci (2012) 0.93
MMP9 regulates the cellular response to inflammation after skeletal injury. Bone (2012) 0.91
Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis. J Am Coll Surg (2012) 0.91
Regenerative medicine: then and now--an update of recent history into future possibilities. J Cell Mol Med (2010) 0.90
Characterization of mesenchymal stem cells derived from rat bone marrow and adipose tissue: a comparative study. Int J Stem Cells (2014) 0.90
Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned? Stem Cell Res Ther (2014) 0.90
Expression of blood group genes by mesenchymal stem cells. Br J Haematol (2011) 0.89
Purinergic receptors and nucleotide processing ectoenzymes: Their roles in regulating mesenchymal stem cell functions. World J Stem Cells (2014) 0.89
Effects of severe hypoxia on bone marrow mesenchymal stem cells differentiation potential. Stem Cells Int (2013) 0.88
Cell therapy in bone healing disorders. Orthop Rev (Pavia) (2010) 0.87
Transcription factor rational design improves directed differentiation of human mesenchymal stem cells into skeletal myocytes. Mol Ther (2011) 0.85
Labeling of mesenchymal stromal cells with iron oxide-poly(L-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging properties. Cytotherapy (2011) 0.84
A double mechanism for the mesenchymal stem cells' positive effect on pancreatic islets. PLoS One (2014) 0.82
The human gastrointestinal tract, a potential autologous neural stem cell source. PLoS One (2013) 0.82
Transplantation of placenta-derived mesenchymal stem cell-induced neural stem cells to treat spinal cord injury. Neural Regen Res (2014) 0.81
Adipose stromal cells contain phenotypically distinct adipogenic progenitors derived from neural crest. PLoS One (2013) 0.81
Promising cellular therapeutics for prevention or management of graft-versus-host disease (a review). Placenta (2011) 0.81
Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification. Tissue Eng Part C Methods (2011) 0.81
Wharton's Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease. Pharmaceuticals (Basel) (2015) 0.80
Persistent DNA damage-induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells. J Cell Mol Med (2015) 0.80
The Potential of GMP-Compliant Platelet Lysate to Induce a Permissive State for Cardiovascular Transdifferentiation in Human Mediastinal Adipose Tissue-Derived Mesenchymal Stem Cells. Biomed Res Int (2015) 0.79
Effects of CoCl2 on multi-lineage differentiation of C3H/10T1/2 mesenchymal stem cells. Korean J Physiol Pharmacol (2015) 0.78
Delivering stem cells to the healthy heart on biological sutures: effects on regional mechanical function. J Tissue Eng Regen Med (2014) 0.78
Establishment of a pancreatic β cell proliferation model in vitro and a platform for diabetes drug screening. Cytotechnology (2013) 0.78
Designing 3D Mesenchymal Stem Cell Sheets Merging Magnetic and Fluorescent Features: When Cell Sheet Technology Meets Image-Guided Cell Therapy. Theranostics (2016) 0.77
High throughput transcriptome profiling of lithium stimulated human mesenchymal stem cells reveals priming towards osteoblastic lineage. PLoS One (2013) 0.77
Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy. Adv Wound Care (New Rochelle) (2016) 0.77
In vitro differentiation of endometrial regenerative cells into smooth muscle cells: Α potential approach for the management of pelvic organ prolapse. Int J Mol Med (2016) 0.77
In vitro and In vivo Model Systems for Hemophilia A Gene Therapy. J Genet Syndr Gene Ther (2013) 0.76
Glucocorticoid Cell Priming Enhances Transfection Outcomes in Adult Human Mesenchymal Stem Cells. Mol Ther (2015) 0.76
Therapeutic application of stem cells in gastroenterology: an up-date. World J Gastroenterol (2011) 0.76
In Vivo Differentiation of Mesenchymal Stem Cells into Insulin Producing Cells on Electrospun Poly-L-Lactide Acid Scaffolds Coated with Matricaria chamomilla L. Oil. Cell J (2016) 0.75
Bone Physiology, Biomaterial and the Effect of Mechanical/Physical Microenvironment on MSC Osteogenesis: A Tribute to Shu Chien's 80th Birthday. Cell Mol Bioeng (2011) 0.75
Removal from adherent culture contributes to apoptosis in human bone marrow mesenchymal stem cells. Mol Med Rep (2017) 0.75
Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget (2017) 0.75
Hybrid composites of mesenchymal stem cell sheets, hydroxyapatite, and platelet-rich fibrin granules for bone regeneration in a rabbit calvarial critical-size defect model. Exp Ther Med (2017) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Matrix elasticity directs stem cell lineage specification. Cell (2006) 43.00
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature (2007) 15.20
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet (2008) 12.59
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet (2004) 11.77
Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med (1999) 9.73
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood (2002) 9.40
Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells (2007) 8.64
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med (2003) 8.46
Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation (2002) 7.97
Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med (2005) 7.66
Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells (2007) 7.57
Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A (2003) 7.41
Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature (2002) 7.28
Immunomodulatory properties of mesenchymal stromal cells. Blood (2007) 6.97
Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet (2003) 6.95
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol (2002) 6.92
Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res (2004) 6.49
Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation (2004) 6.43
Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A (2005) 6.16
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A (2002) 6.05
Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One (2008) 5.91
Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells (2007) 5.83
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood (2005) 5.82
Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol (2004) 5.82
Stem-cell therapy for cardiac disease. Nature (2008) 5.75
Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol (1976) 5.71
Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol (2007) 5.66
Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst (2004) 5.39
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol (2003) 5.35
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation (2006) 5.33
Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol (2005) 5.31
Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation (2003) 5.20
Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A (2007) 5.17
Retracted Spontaneous human adult stem cell transformation. Cancer Res (2005) 4.95
Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A (2000) 4.72
Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem (1997) 4.68
Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum (2001) 4.57
Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol (2005) 4.57
Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology (2002) 4.45
A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia (2006) 4.39
Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One (2008) 4.37
Clinical applications of angiogenic growth factors and their inhibitors. Nat Med (1999) 4.26
Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation (2005) 4.20
In search of the in vivo identity of mesenchymal stem cells. Stem Cells (2008) 4.17
Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood (2003) 4.09
Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol (2000) 3.94
Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A (2007) 3.74
Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med (2001) 3.73
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia (2008) 3.69
Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol (2008) 3.67
Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol (2001) 3.66
Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A (2006) 3.48
Retracted Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood (2001) 3.46
Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol (2005) 3.40
Aging of mesenchymal stem cell in vitro. BMC Cell Biol (2006) 3.32
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant (2002) 3.24
Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol (2002) 3.20
Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res (2007) 3.19
Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells (2008) 3.12
Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) (2005) 3.00
Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res (2007) 2.98
Potential risks of bone marrow cell transplantation into infarcted hearts. Blood (2007) 2.97
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther (2004) 2.97
Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci (2004) 2.96
Vascularization in tissue engineering. Trends Biotechnol (2008) 2.93
Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg (2008) 2.87
Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther (2006) 2.85
SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood (2006) 2.83
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant (2005) 2.82
Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int (2007) 2.75
Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976) (2002) 2.74
A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum (2005) 2.65
Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res (2003) 2.61
Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci U S A (2003) 2.59
Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood (2003) 2.57
Differential subcellular localization of the RI and RII Na+ channel subtypes in central neurons. Neuron (1989) 2.53
Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells (2005) 2.52
Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol (2002) 2.51
Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood (2006) 2.49
Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells (2007) 2.45
Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood (2002) 2.43
Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia (2003) 2.39
Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res (2000) 2.37
Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant (2004) 2.36
Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant (1995) 2.35
Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci U S A (2005) 2.26
Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther (2008) 2.25
The emerging biology of satellite cells and their therapeutic potential. Trends Mol Med (2008) 2.24
Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci (2003) 2.22
Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec (2001) 2.18
Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery (2003) 2.16
Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med (2004) 2.16
Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum (2005) 2.13
Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells (2004) 2.12
Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica (2007) 2.07
Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol (2002) 2.05
Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am (2003) 1.97
Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood. BMC Genomics (2010) 1.84
Demonstration of intramedullary tuberculomas by magnetic resonance imaging: a report of two cases. Br J Radiol (1991) 1.50
Phosphate balance in continuous venovenous hemofiltration. Am J Kidney Dis (2013) 1.48
Mesenchymal stem cells: molecular targets for tissue engineering. Stem Cells Dev (2007) 1.46
Etiological profile of stroke and its relation with prothrombotic states. Indian J Pediatr (2008) 1.44
Antimicrobial resistance in Enterococcus faecalis at a tertiary care centre of northern India. Indian J Med Res (2003) 1.43
A psychiatric study of amputees. Br J Psychiatry (1982) 1.43
Diffusion-weighted magnetic resonance imaging and magnetic resonance spectroscopy in the evaluation of focal cerebral tubercular lesions. Acta Radiol (2004) 1.41
Is there a need to do routine sonological, urodynamic study and cystourethroscopic evaluation of patients with simple hypospadias? Pediatr Surg Int (2010) 1.41
Stromal-derived factor-1/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow. Stem Cells Dev (2011) 1.37
Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects. J Cancer Res Ther (2009) 1.25
Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection. Infect Immun (2005) 1.23
Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo. J Immunol (2006) 1.22
Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosis. PLoS One (2012) 1.10
Gastric volvulus with perforation in association with congenital diaphragmatic hernia. Indian J Pediatr (2004) 1.09
Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells. Infect Immun (2005) 1.05
Phantom limb: a phenomenological study. Br J Psychiatry (1982) 1.03
Intraventricular migration of an entire VP shunt. Indian Pediatr (2005) 1.02
In vitro antifungal activity of hydroxychavicol isolated from Piper betle L. Ann Clin Microbiol Antimicrob (2010) 1.02
Management of anorectal malformations in Varanasi, India: a long-term review of single and three stage procedures. Pediatr Surg Int (2005) 1.02
Stem cell therapy: a novel & futuristic treatment modality for disaster injuries. Indian J Med Res (2012) 1.00
Endothelin-1 gene variants and levels associate with adaptation to hypobaric hypoxia in high-altitude natives. Biochem Biophys Res Commun (2006) 0.99
Primary spinal echinococcosis causing paraplegia: case report with MR and pathologic correlation. AJNR Am J Neuroradiol (1991) 0.98
Coordination modes of a schiff base pentadentate derivative of 4-aminoantipyrine with cobalt(II), nickel(II) and copper(II) metal ions: synthesis, spectroscopic and antimicrobial studies. Molecules (2009) 0.98
Stem cell c-KIT and HOXB4 genes: critical roles and mechanisms in self-renewal, proliferation, and differentiation. Stem Cells Dev (2006) 0.97
Acute disseminated encephalomyelitis--a case series. Indian Pediatr (2005) 0.96
Low-dose radiation therapy of cancer: role of immune enhancement. Expert Rev Anticancer Ther (2011) 0.96
Hematopoietic stem cell antigen CD34: role in adhesion or homing. Stem Cells Dev (2006) 0.95
Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis. Stem Cells Dev (2005) 0.95
Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging. Australas Radiol (2004) 0.94
Inter-application variation of dose and spatial location of D(2cm(3)) volumes of OARs during MR image based cervix brachytherapy. Radiother Oncol (2013) 0.93
Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis. J Microbiol Methods (2011) 0.93
Podophyllum hexandrum Offers Radioprotection by Modulating Free Radical Flux: Role of Aryl-Tetralin Lignans. Evid Based Complement Alternat Med (2006) 0.90
Marginal vacuoles in thyroid aspirates. Acta Cytol (1998) 0.90
A toolbox for tuberculosis diagnosis: an Indian multicentric study (2006-2008): microbiological results. PLoS One (2012) 0.90
Ultrasound-guided fine-needle aspiration cytology diagnosis of gallbladder lesions: a study of 82 cases. Diagn Cytopathol (1998) 0.90
Radiomodulatory and free-radical scavenging activity of the fractionated aquo-alcoholic extract of the adaptogenic nutraceutical (Rhodiola imbricata)--a comparative in vitro assessment with ascorbate. J Diet Suppl (2008) 0.90
Esophageal replacement in the neonatal period in infants with esophageal atresia and tracheoesophageal fistula. J Pediatr Surg (2007) 0.90
A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis. PLoS One (2013) 0.89
Isolation, characterization and antimicrobial evaluation of a novel compound N-octacosan 7β ol, from Fumaria parviflora Lam. BMC Complement Altern Med (2014) 0.89
Ultrasound guided percutaneous fine needle aspiration cytology of pancreas: a review of 61 cases. Trop Gastroenterol (1996) 0.89
Antimicrobial drug resistance as determined by the E-test in Campylobacter jejuni, C. coli, and C. lari isolates from the ceca of broiler and layer chickens in Grenada. Comp Immunol Microbiol Infect Dis (2008) 0.88
Exploration of antimicrobial and antioxidant potential of newly synthesized 2,3-disubstituted quinazoline-4(3H)-ones. Bioorg Med Chem Lett (2011) 0.88
Oviposition and flight orientation response of Aedes aegypti to certain aromatic aryl hydrazono esters. Parasitol Res (2012) 0.87
Tc-99m ciprofloxacin scans for detection of tubercular bone infection. Clin Nucl Med (2007) 0.87
Development of a cell-based assay for screening of phosphodiesterase 10A (PDE10A) inhibitors using a stable recombinant HEK-293 cell line expressing high levels of PDE10A. Biotechnol Appl Biochem (2008) 0.86
Botulinum toxin: bioweapon & magic drug. Indian J Med Res (2010) 0.86
Infectivity and virulence of Leishmania donovani promastigotes: a role for media, source, and strain of parasite. J Eukaryot Microbiol (2002) 0.85
Role of guided fine needle aspiration cytology in diagnosis and classification of liver malignancies. Trop Gastroenterol (1998) 0.85
Specific contribution of lamin A and lamin C in the development of laminopathies. Exp Cell Res (2008) 0.85
Functional magnetic resonance imaging of the primary motor cortex in humans: response to increased functional demands. J Biosci (2001) 0.84
Extracts of Artemisia annua leaves and seeds mediate programmed cell death in Leishmania donovani. J Med Microbiol (2012) 0.84
Protection of normal cells and tissues during radio- and chemosensitization of tumors by 2-deoxy-D-glucose. J Cancer Res Ther (2009) 0.84
Esophageal atresia: the total care in a high-risk population. Semin Pediatr Surg (2008) 0.83
4-Methyl-7-(tetradecanoyl)-2H-1-benzopyran-2-one: a novel DNA topoisomerase II inhibitor with adulticidal and embryostatic activity against sub-periodic Brugia malayi. Parasitol Res (2003) 0.83
Synthesis of 2-sulfanyl-6-methyl-1,4-dihydropyrimidines as a new class of antifilarial agents. Eur J Med Chem (2008) 0.82
Small round cell tumors of the abdomen and thorax. Role of fine needle aspiration cytologic features in the diagnosis and differential diagnosis. Acta Cytol (1997) 0.82
Meconeum hydrocele presenting as a labial mass. Indian Pediatr (2005) 0.82
Effect of number of replicate electrocardiograms recorded at each time point in a thorough QT study on sample size and study cost. J Clin Pharmacol (2010) 0.82
Enhanced antibacterial activity of bimetallic gold-silver core-shell nanoparticles at low silver concentration. Nanoscale (2011) 0.82
Atypical diffusion-weighted magnetic resonance findings in glioblastoma multiforme. Australas Radiol (2004) 0.82
Novel RuvB nuclear ATPase is specific to intraerythrocytic mitosis during schizogony of Plasmodium falciparum. Mol Biochem Parasitol (2012) 0.82
Correlation of plasma trough levels of imatinib with molecular response in patients with chronic myeloid leukemia. Leuk Lymphoma (2014) 0.81
Frontal lobe proton magnetic-resonance spectroscopy in Graves' disease: a pilot study. Psychoneuroendocrinology (1998) 0.81
Synthesis and bioevaluation of glycosyl ureas as alpha-glucosidase inhibitors and their effect on mycobacterium. Bioorg Med Chem (2003) 0.81
Zingiber officinale exhibits behavioral radioprotection against radiation-induced CTA in a gender-specific manner. Pharmacol Biochem Behav (2006) 0.81
Structural conservation of residues in BH1 and BH2 domains of Bcl-2 family proteins. FEBS Lett (2005) 0.81
Radiation processed amniotic membranes in the treatment of non-healing ulcers of different etiologies. Cell Tissue Bank (2004) 0.81
Whole body protection against lethal ionizing radiation in mice by REC-2001: a semi-purified fraction of Podophyllum hexandrum. Phytomedicine (2007) 0.81
Comparative deacetylase activity of wild type and mutants of SIRT1. Biochem Biophys Res Commun (2009) 0.80
Potential of Complementary and Alternative Medicine in Preventive Management of Novel H1N1 Flu (Swine Flu) Pandemic: Thwarting Potential Disasters in the Bud. Evid Based Complement Alternat Med (2010) 0.80
Iodine-stabilized Cu nanoparticle chitosan composite for antibacterial applications. ACS Appl Mater Interfaces (2012) 0.80
Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs). J Stem Cells (2015) 0.80
An efficient synthesis of aryloxyphenyl cyclopropyl methanones: a new class of anti-mycobacterial agents. Bioorg Med Chem Lett (2005) 0.80
Protection from radiation-induced mitochondrial and genomic DNA damage by an extract of Hippophae rhamnoides. Environ Mol Mutagen (2006) 0.80
Properties of Air Dried Radiation Processed Amniotic Membranes under Different Storage Conditions. Cell Tissue Bank (2003) 0.80
Can we differentiate true white matter fibers from pseudofibers inside a brain abscess cavity using geometrical diffusion tensor imaging metrics? NMR Biomed (2008) 0.80
Synthesis and antifilarial evaluation of N1,Nn- xylofuranosylated diaminoalkanes. Bioorg Med Chem (2003) 0.80
Synthesis and antimycobacterial activity of 3,5-disubstituted thiadiazine thiones. Bioorg Med Chem (2003) 0.80
In vitro antifungal activities of amphotericin B in combination with acteoside, a phenylethanoid glycoside from Colebrookea oppositifolia. J Med Microbiol (2011) 0.79
Protective efficacy of semi purified fraction of high altitude podophyllum hexandrum rhizomes in lethally irradiated Swiss albino mice. Cell Mol Biol (Noisy-le-grand) (2007) 0.79
Cloning, stable expression of human phosphodiesterase 7A and development of an assay for screening of PDE7 selective inhibitors. Appl Microbiol Biotechnol (2007) 0.79
Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents. Bioorg Med Chem Lett (2004) 0.79
Phosphorous magnetic resonance spectroscopy-based skeletal muscle bioenergetic studies in subclinical hypothyroidism. J Endocrinol Invest (2011) 0.79
Modulation of gamma radiation-inflicted damage in Swiss albino mice by an alcoholic fraction of Podophyllum hexandrum rhizome. J Med Food (2008) 0.79
Apoptosis-like death in Leishmania donovani promastigotes induced by eugenol-rich oil of Syzygium aromaticum. J Med Microbiol (2013) 0.79